Avinash Ramyead1, Michael Kometer2, Erich Studerus1, Susan Koranyi1, Sarah Ittig1, Ute Gschwandtner3, Peter Fuhr3, Anita Riecher-Rössler4. 1. University of Basel Psychiatric Clinics, Center for Gender Research and Early Detection, Basel; 2. Neuropsychopharmacology and Brain Imaging Research Unit, Psychiatric University Hospital, Zurich; 3. Department of Neurology, University Hospital Basel, Basel, Switzerland. 4. University of Basel Psychiatric Clinics, Center for Gender Research and Early Detection, Basel; anita.riecher@upkbs.ch.
Abstract
BACKGROUND: Converging evidence indicates that neural oscillations coordinate activity across brain areas, a process which is seemingly perturbed in schizophrenia. In particular, beta (13-30 Hz) and gamma (30-50 Hz) oscillations were repeatedly found to be disturbed in schizophrenia and linked to clinical symptoms. However, it remains unknown whether abnormalities in current source density (CSD) and lagged phase synchronization of oscillations across distributed regions of the brain already occur in patients with an at-risk mental state (ARMS) for psychosis. METHODS: To further elucidate this issue, we assessed resting-state EEG data of 63 ARMS patients and 29 healthy controls (HC). Twenty-three ARMS patients later made a transition to psychosis (ARMS-T) and 40 did not (ARMS-NT). CSD and lagged phase synchronization of neural oscillations across brain areas were assessed using eLORETA and their relationships to neurocognitive deficits and clinical symptoms were analyzed using linear mixed-effects models. RESULTS: ARMS-T patients showed higher gamma activity in the medial prefrontal cortex compared to HC, which was associated with abstract reasoning abilities in ARMS-T. Furthermore, in ARMS-T patients lagged phase synchronization of beta oscillations decreased more over Euclidian distance compared to ARMS-NT and HC. Finally, this steep spatial decrease of phase synchronicity was most pronounced in ARMS-T patients with high positive and negative symptoms scores. CONCLUSIONS: These results indicate that patients who will later make the transition to psychosis are characterized by impairments in localized and synchronized neural oscillations providing new insights into the pathophysiological mechanisms of schizophrenic psychoses and may be used to improve the prediction of psychosis.
BACKGROUND: Converging evidence indicates that neural oscillations coordinate activity across brain areas, a process which is seemingly perturbed in schizophrenia. In particular, beta (13-30 Hz) and gamma (30-50 Hz) oscillations were repeatedly found to be disturbed in schizophrenia and linked to clinical symptoms. However, it remains unknown whether abnormalities in current source density (CSD) and lagged phase synchronization of oscillations across distributed regions of the brain already occur in patients with an at-risk mental state (ARMS) for psychosis. METHODS: To further elucidate this issue, we assessed resting-state EEG data of 63 ARMS patients and 29 healthy controls (HC). Twenty-three ARMS patients later made a transition to psychosis (ARMS-T) and 40 did not (ARMS-NT). CSD and lagged phase synchronization of neural oscillations across brain areas were assessed using eLORETA and their relationships to neurocognitive deficits and clinical symptoms were analyzed using linear mixed-effects models. RESULTS:ARMS-Tpatients showed higher gamma activity in the medial prefrontal cortex compared to HC, which was associated with abstract reasoning abilities in ARMS-T. Furthermore, in ARMS-Tpatients lagged phase synchronization of beta oscillations decreased more over Euclidian distance compared to ARMS-NT and HC. Finally, this steep spatial decrease of phase synchronicity was most pronounced in ARMS-Tpatients with high positive and negative symptoms scores. CONCLUSIONS: These results indicate that patients who will later make the transition to psychosis are characterized by impairments in localized and synchronized neural oscillations providing new insights into the pathophysiological mechanisms of schizophrenic psychoses and may be used to improve the prediction of psychosis.
Authors: Ronan Zimmermann; Ute Gschwandtner; Frank H Wilhelm; Marlon O Pflueger; Anita Riecher-Rössler; Peter Fuhr Journal: Schizophr Res Date: 2010-09-20 Impact factor: 4.939
Authors: Gregory A Light; Jung Lung Hsu; Ming H Hsieh; Katrin Meyer-Gomes; Joyce Sprock; Neal R Swerdlow; David L Braff Journal: Biol Psychiatry Date: 2006-08-07 Impact factor: 13.382
Authors: Michael J Minzenberg; Alana J Firl; Jong H Yoon; Glenn C Gomes; Celeste Reinking; Cameron S Carter Journal: Neuropsychopharmacology Date: 2010-09-08 Impact factor: 7.853
Authors: Michael Kometer; Thomas Pokorny; Erich Seifritz; Franz X Volleinweider Journal: Psychopharmacology (Berl) Date: 2015-08-01 Impact factor: 4.530
Authors: Robin von Rotz; Michael Kometer; Dario Dornbierer; Jürg Gertsch; M Salomé Gachet; Franz X Vollenweider; Erich Seifritz; Oliver G Bosch; Boris B Quednow Journal: Psychopharmacology (Berl) Date: 2017-04-20 Impact factor: 4.530
Authors: Saskia Steinmann; Rom Amselberg; Bastian Cheng; Götz Thomalla; Andreas K Engel; Gregor Leicht; Christoph Mulert Journal: Sci Rep Date: 2018-10-18 Impact factor: 4.379